ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos595.2 M546 M579.3 M552.4 M538.6 M2.22 BInvestigación y desarrollo——————Beneficio operativo216.5 M326 M394.5 M396.6 M267.6 M1.38 BTotal de ingresos no operativos31.2 M5.5 M-31 M1.6 M-16.1 M-40 MGastos por intereses, netos de intereses capitalizados63.4 M56 M57.1 M56 M55 M224.1 MIngresos no operativos, una vez deducidos los gastos por intereses-48.6 M-49.5 M-55.4 M-52.5 M-51.7 M-209.1 MIngresos/gastos extraordinarios16.4 M-1 M-32.7 M-1.9 M-19.4 M-55 MBeneficio antes de impuestos958.8 M2.73 B2.88 B2.94 B1.1 B9.64 BParticipación en los beneficios-700 K-300 K-1.7 M-5.2 M-6.1 M-13.3 MImpuestos40.2 M62.2 M66.4 M75.5 M25.7 M229.8 MParticipación minoritaria200 K200 K400 K400 K200 K1.2 MOtros ingresos/gastos después de impuestos——————Beneficio neto antes de actividades interrumpidas143.4 M212.8 M237.9 M261.1 M164.7 M876.5 MOperaciones suspendidas0———0—Beneficio neto143.4 M212.8 M237.9 M261.1 M164.7 M876.5 MAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas143.4 M212.8 M237.9 M261.1 M164.7 M876.5 MBeneficio básico por acción1.722.542.853.142.0110.54Beneficio por acción diluido1.722.522.843.121.9810.46Número medio de acciones ordinarias83.9 M83.6 M83.4 M83.1 M83.2 M333.3 MAcciones diluidas84.4 M84.3 M83.9 M83.7 M83.8 M335.7 MEBITDA223.8 M494.3 M568.9 M574.9 M340.8 M1.98 BEBIT53.2 M327.5 M398.6 M403.9 M167.8 M1.3 BCosto de los ingresos2.43 B2.4 B2.48 B2.54 B2.52 B9.94 BOtros costes de producción——————Amortización y depreciación (flujo de caja)170.6 M166.8 M170.3 M171 M173 M681.1 M
Labcorp Holdings Inc
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.